Keynote Lectures

Keynote Lecture

EUROTOX Lecture Award ​

EUROTOX - SOT Debate​

The annual SOT/EUROTOX debate features leading toxicologists presenting contrasting perspectives on a controversial or pressing issue in toxicology. The debate began in the early 1990s and has been a highly anticipated event ever since.

This year, the debaters will address the proposition “Do the Societal Benefits of Plastic Outweigh the Risks of Microplastic Contamination?” The debaters will introduce the issues that should be considered in weighing the costs and benefits of plastic. Critical to this debate are considerations, global economic impacts of plastic use, emissions, natural resources, energy consumption, cost, and lifecycle.

Relevant questions include:

(1) What are the most significant societal benefits of plastic use?

(2) What are the primary sources of microplastic contamination and how do they enter ecosystems and human bodies?

(3) What is known about the health risks of microplastics to humans and wildlife?

(4) How do the long-term environmental costs of microplastic pollution compare to the benefits of plastic use?

In addition to inclusion as a Keynote Lecture at this congress, this debate took place already (with the debaters having taken the reverse positions) in San Diego, US, during the 2026 SOT Annual Meeting, March 22-25.

Keynote Lecture

Understanding the interactions of nanomaterials and other advanced materials with the immune system is of paramount importance for the safe and sustainable development and use of these materials. Here, we will discuss studies of conventional nanomaterials such as SiO2 and TiO2 along with emerging two-dimensional (2D) materials including graphene-based materials and transition metal carbides and nitrides (collectively known as MXenes) with respect to their (reciprocal) interactions with cells of the innate immune system. We will discuss the activation of inflammasomes, cytosolic receptors that play a key role in sensing immunological ‘danger’. Specially, how nanomaterials evoke sterile inflammation with the secretion of pro-inflammatory mediators such as interleukin (IL)-1β. We will also address the degradability of nanomaterials and other advanced materials and the implications for the hazard assessment of such materials. Finally, we will discuss recent studies on the interplay between engineered nanomaterials, the immune system, and the microbiota, our ‘forgotten organ’ consisting of bacteria and other microorganisms that dwell in and on the human body. Overall, we seek to highlight whether nanomaterials and other advanced materials evoke novel immunotoxicological effects or whether the observed effects are ancient and conserved and, therefore, in principal, predictable.

HESI CITE Lecture

Keynote Lecture

Consent Management Platform by Real Cookie Banner